Pfizer has set its FY2026 profit forecast below analyst estimates, blaming projected losses on waning Covid vaccine sales and the looming patent cliff faced by some of its best-selling assets. Through ...
Pfizer has adjusted its FY2026 profit forecast to between $59.5bn and $62.5bn amid declining Covid vaccine sales and the loss of exclusivity of some of its assets. Image credit: Poetra.RH via ...
Pfizer Inc. (NYSE: PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback